Publisher: BioSpace


Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium

In the Media Icon

New data will be presented about Precise® Molecular Residual Disease (MRD) Test and MyRisk® Hereditary Cancer Test


Fertility Market Size to Lead USD 85.5 Billion by 2034 Driven by Rising Demand for IVF Diagnostic

In the Media Icon

According to Statifacts, The global fertility market size surpassed US$ 36.5 billion in 2024 and is estimated to hit around US$ 85.5 billion by 2034, expanding at a CAGR of 8.9% from 2025 to 2034.


Dr. Adam S. Arthur Joins inTRAvent Medical as the Chief Clinical Strategy Officer to Lead Clinical Strategy and Guide Platform Development

In the Media Icon

inTRAvent Medical, a medical device company dedicated to bringing intra-operative imaging and navigation to the bedside to improve neurosurgical procedures, proudly announces the appointment of Dr. Adam S. Arthur, MD, MPH, as Chief Clinical Strategy Officer (CCSO).


Imperative Care Announces Independent Randomized Clinical Trial for Treatment of M2 Occlusions in Stroke Patients

In the Media Icon

Imperative Care, Inc. today announced it will fund an investigator-initiated, multicenter, randomized, controlled clinical trial comparing aspiration thrombectomy with the Zoom Stroke System plus best medical treatment versus best medical treatment alone.


Bryn Pharma to present positive results from new analyses supporting use of its epinephrine nasal spray in adults at the AAAAI 2024 annual meeting

In the Media Icon

“Unfortunately, there are instances where a single dose of epinephrine does not provide adequate relief and a second dose may be required to effectively treat more severe, progressive, or life-threatening anaphylaxis,” said Jay Lieberman, M.D., professor at the University of Tennessee Health Science Center and chair of the food allergy committee for the American College of Allergy, Asthma,… Read More


Le Bonheur Children’s Hospital Announces New President

In the Media Icon

Le Bonheur Children’s Hospital announced today that Michael Wiggins, MBA, FACHE, will become its next president. He will begin his tenure April 8, 2019. Wiggins comes to Le Bonheur from Children’s Health in Dallas, Texas, where he served as senior vice president of Clinical Operations and the Northern Market and administrator of the Children’s Medical… Read More